Hematopoietic Stem-Cell Transplant Utilization in Relapsed/Refractory Hodgkin Lymphoma: A Population-Level Analysis of Statewide Claims Data.
Anem WaheedAngie Mae RoddayAnita J KumarKenneth B MillerSusan K ParsonsPublished in: JCO clinical cancer informatics (2022)
We used the Massachusetts APCD to create a cohort of patients age < 65 years with relapsed/refractory HL. Our findings support the use of APCD for the large-scale analysis of patient characteristics, treatment patterns, and outcomes for young adult patients with hematologic malignancies.
Keyphrases
- hodgkin lymphoma
- hematopoietic stem cell
- end stage renal disease
- acute lymphoblastic leukemia
- acute myeloid leukemia
- ejection fraction
- chronic kidney disease
- diffuse large b cell lymphoma
- multiple myeloma
- newly diagnosed
- prognostic factors
- case report
- peritoneal dialysis
- type diabetes
- metabolic syndrome
- combination therapy
- middle aged
- adipose tissue
- skeletal muscle
- replacement therapy